25 /100
LOW RISK
Score updated Jul 13, 2026

BLFY — Blue Foundry Bancorp Dilution Risk Tracker

Track BLFY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BLFY — Get alerts when the score changes →

As of July 13, 2026, Blue Foundry Bancorp (BLFY) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Blue Foundry Bancorp has a market capitalization of $274.88M, 19.13M shares outstanding, 110 institutional holders tracked. Key dilution vectors include approximately 48 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
35
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BLFY.
🔔 Track BLFY — Get forecast alerts →

💹 Market Data

Market Cap$274.88M
Shares Outstanding19.13M
Float13.97M
Cash$53.14M
Debt$326.88M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 9.8% shares (2026Q1 vs prior)
110 institutional holders · 13.56M shares
#1 GLAZER CAPITAL, LLC 1.72M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 1.53M shares
#3 BlackRock, Inc. 1.27M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest550.1K
Days to Cover2.6
% of Float3.9%
FINRA data as of Mar 31, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for BLFY Shareholders

Blue Foundry Bancorp (BLFY) has a DilutionScore of 25/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for BLFY shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BLFY in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BLFY alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BLFY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BLFY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BLFY
📊 BLFY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BLFY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.